Predictors and long-term patterns of medication adherence to glaucoma treatment in Denmark-an observational registry study of 30 100 Danish patients with glaucoma

被引:1
作者
Kolko, Miriam [1 ,2 ]
Hansen, Rikke Faergemann [3 ]
Dal, Louise G. [4 ]
Sabelstrom, Emma [4 ]
Brandel, Magnus [4 ]
Bentsen, Andreas Hoiberg [3 ]
Falch-Joergensen, Anne Cathrine [3 ]
机构
[1] Univ Copenhagen, Fac Hlth Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark
[2] Rigshosp Glostrup, Rigshospitalet Glostrup, Glostrup, Denmark
[3] Real World Evidence, Signum Life Sci, Copenhagen, Denmark
[4] AbbVie A S, Copenhagen, Denmark
关键词
Glaucoma; Epidemiology; Public health; Treatment Medical; VISUAL-FIELD PROGRESSION; OCULAR HYPERTENSION; INTRAOCULAR-PRESSURE; INTERVENTION; AGIS; BARRIERS; DISEASE; QUALITY; SYSTEM; COSTS;
D O I
10.1136/bmjophth-2023-001607
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Self-treatment with glaucoma medication (eye drops) has been associated with adherence challenges. Poor adherence results in worse outcomes in terms of visual field loss.Objective To investigate patterns in medication adherence among Danish patients with glaucoma in relation to selected predictors of adherence, long-term adherence patterns, and long-term societal economic consequences of poor adherence.Methods and analysis This register-based study included 30 100 glaucoma patients followed for 10 years between 2000 and 2018. Glaucoma was identified from the Danish national registers by diagnosis of Open Angle Glaucoma and/or by redeemed prescriptions of glaucoma medication. Logistic regression models were applied to estimate patient characteristics related to medical adherence. Diagnosis-related group fees were applied to estimate healthcare costs.Results High adherence in the first year(s) of treatment was less likely among men (ORfirst year: 0.78, 95% CI: 0.75 to 0.82), younger individuals and among those with a positive Charlson Comorbidity Index (CCI) score (ORfirst year/CCI >= 3: 0.71, 95% CI: 0.63 to 0.80). Adherence in the first year and in the first two years was associated with adherence in the fifth (ORfirst year: 4.55, 95% CI: 4.30 to 4.82/ORfirst two years: 6.47, 95% CI: 6.10 to 6.86) as with adherence in the 10th year with slightly lower estimates. Being medical adherent was related to higher costs related to glaucoma medication after 5 and 10 years comparing with poor adherence, whereas poor adherence was associated with a marked increase in long-term costs for hospital contacts.Conclusion Increasing age, female sex and low comorbidity score are correlated with better adherence to glaucoma treatment. Adherence in the first years of treatment may be a good predictor for future adherence. In the long term, patients with poor adherence are overall more expensive to society in terms of hospital contacts.
引用
收藏
页数:9
相关论文
共 48 条
[11]   Risk Factors for Poor Adherence to Eyedrops in Electronically Monitored Patients with Glaucoma [J].
Friedman, David S. ;
Okeke, Constance O. ;
Jampel, Henry D. ;
Ying, Gui-shuang ;
Plyler, Ryan J. ;
Jiang, Yuzhen ;
Quigley, Harry A. .
OPHTHALMOLOGY, 2009, 116 (06) :1097-1105
[12]  
Gaasterland DE, 1998, OPHTHALMOLOGY, V105, P1146
[13]   Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial [J].
Gazzard, Gus ;
Konstantakopoulou, Evgenia ;
Garway-Heath, David ;
Garg, Anurag ;
Vickerstaff, Victoria ;
Hunter, Rachael ;
Ambler, Gareth ;
Bunce, Catey ;
Wormald, Richard ;
Nathwani, Neil ;
Barton, Keith ;
Rubin, Gary ;
Buszewicz, Marta ;
Bourne, Rupert ;
Broadway, David ;
Bunce, Catey ;
Buszewicz, Marta ;
Davis, Amanda ;
Jayaram, Hari ;
Jiang, Yuzhen ;
Lim, Sheng ;
Liput, Joanna ;
Manners, Timothy ;
Morris, Stephen ;
Strouthidis, Nicholas ;
Wilson, Sarah ;
Wormald, Richard ;
Zhu, Haogang .
LANCET, 2019, 393 (10180) :1505-1516
[14]   Reduction of intraocular pressure and glaucoma progression - Results from the early manifest glaucoma trial [J].
Heijl, A ;
Leske, MC ;
Bengtsson, B ;
Hyman, L ;
Bengtsson, B ;
Hussein, M .
ARCHIVES OF OPHTHALMOLOGY, 2002, 120 (10) :1268-1279
[15]  
Higginbotham EJ, 1998, OPHTHALMOLOGY, V105, P1137
[16]   Glaucoma: now and beyond [J].
Jayaram, Hari ;
Kolko, Miriam ;
Friedman, David S. ;
Gazzard, Gus .
LANCET, 2023, 402 (10414) :1788-1801
[17]  
Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701
[18]   The Danish National Prescription Registry [J].
Kildemoes, Helle Wallach ;
Sorensen, Henrik Toft ;
Hallas, Jesper .
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2011, 39 :38-41
[19]   Treatment patterns and medication adherence of patients with glaucoma in South Korea [J].
Kim, Chan Yun ;
Park, Ki Ho ;
Ahn, Jaehong ;
Ahn, Myung-Douk ;
Cha, Soon Cheol ;
Kim, Ho Soong ;
Kim, Joon Mo ;
Kim, Moon Jung ;
Kim, Tae-Woo ;
Kim, Yong Yeon ;
Lee, Ji Woong ;
Park, Sang-Woo ;
Sohn, Yong Ho ;
Sung, Kyung Rim ;
Yoo, Chungkwon ;
Cha, Jinhye ;
Kim, Young-Joo .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2017, 101 (06) :801-807
[20]   The Prevalence and Incidence of Glaucoma in Denmark in a Fifteen Year Period: A Nationwide Study [J].
Kolko, Miriam ;
Horwitz, Anna ;
Thygesen, John ;
Jeppesen, Jorgen ;
Torp-Pedersen, Christian .
PLOS ONE, 2015, 10 (07)